Recent discussions on X about Q32 Bio Inc. (QTTB) have been notably active, largely driven by the company’s upcoming participation in the 2025 Wells Fargo Healthcare Conference on September 4. Many users are focusing on the potential impact of Q32 Bio’s presentations on alopecia areata and autoimmune therapy pipelines, with some expressing optimism about future growth prospects. The biotech sector’s volatility keeps the conversation lively and speculative.
Posts on X also highlight a mix of curiosity and caution regarding QTTB’s clinical-stage developments, with some users debating the timelines for meaningful results from their pipeline. The tone of these discussions often swings between hope for breakthroughs and concern over the inherent risks of biotech investments. This ongoing dialogue reflects a broader interest in how Q32 Bio might position itself in a competitive market.
Note: This discussion summary was generated from an AI condensation of post data.
Q32 Bio Inc. Insider Trading Activity
Q32 Bio Inc. insiders have traded $QTTB stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $QTTB stock by insiders over the last 6 months:
- JODIE POPE MORRISON (CEO) sold 10,494 shares for an estimated $18,899
- LEE KALOWSKI (CFO and President) sold 4,240 shares for an estimated $7,636
- SHELIA M. VIOLETTE (Chief Scientific Officer) sold 2,990 shares for an estimated $5,384
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Q32 Bio Inc. Hedge Fund Activity
We have seen 22 institutional investors add shares of Q32 Bio Inc. stock to their portfolio, and 66 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SIO CAPITAL MANAGEMENT, LLC removed 697,413 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $1,150,731
- TEMASEK HOLDINGS (PRIVATE) LTD removed 313,943 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $518,005
- BLACKROCK, INC. removed 278,694 shares (-60.9%) from their portfolio in Q2 2025, for an estimated $415,254
- MILLENNIUM MANAGEMENT LLC added 130,379 shares (+inf%) to their portfolio in Q2 2025, for an estimated $194,264
- STATE STREET CORP removed 110,561 shares (-80.4%) from their portfolio in Q2 2025, for an estimated $164,735
- MONACO ASSET MANAGEMENT SAM added 86,486 shares (+17.1%) to their portfolio in Q2 2025, for an estimated $128,864
- ARROWMARK COLORADO HOLDINGS LLC removed 81,482 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $134,445
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
